MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

28 Jan 2021 Evaluate

Glenmark Pharmaceuticals has informed that it has enclosed a media release on 28th January 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg’ which is self-explanatory.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1776.55
Dr. Reddys Labs. 1189.25
Cipla 1315.70
Lupin 1999.00
Zydus Lifesciences 1119.70
View more..